Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis

Objective Optimal platelet inhibition is an important therapeutic adjunct in patients with carotid artery stenosis undergoing carotid artery stenting (CAS). Clopidogrel resistance is associated with increased periprocedural thromboembolic complications from neurovascular stent placement procedures....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of vascular surgery 2014-03, Vol.59 (3), p.761-767
Hauptverfasser:	Nakagawa, Ichiro, MD, PhD, Wada, Takeshi, MD, Park, Hun Soo, MD, Nishimura, Fumihiko, MD, PhD, Yamada, Syuichi, MD, PhD, Nakagawa, Hiroyuki, MD, PhD, Kichikawa, Kimihiko, MD, PhD, Nakase, Hiroyuki, MD, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angioplasty - adverse effects Angioplasty - instrumentation Aspirin - therapeutic use Brain Ischemia - blood Brain Ischemia - diagnosis Brain Ischemia - etiology Brain Ischemia - prevention & control Carotid Stenosis - blood Carotid Stenosis - complications Carotid Stenosis - diagnosis Carotid Stenosis - therapy Diffusion Magnetic Resonance Imaging Drug Resistance Drug Therapy, Combination Female Hemorrhage - chemically induced Humans Male Middle Aged Platelet Aggregation - drug effects Platelet Aggregation Inhibitors - therapeutic use Platelet Function Tests Prospective Studies Stents Surgery Tetrazoles - therapeutic use Ticlopidine - analogs & derivatives Ticlopidine - therapeutic use Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!